يعرض 1 - 10 نتائج من 284 نتيجة بحث عن '"Guilhot, Joëlle"', وقت الاستعلام: 1.51s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Model-based inference and classification of immunological control mechanisms from TKI cessation and dose reduction in CML patients

    المؤلفون: Hähnel, Tom, Baldow, Christoph, Guilhot, Joëlle, Guilhot, François, Saussele, Susanne, Mustjoki, Satu, Jilg, Stefanie, Jost, Philipp J., Dulucq, Stephanie, Mahon, François-Xavier, Roeder, Ingo, Fassoni, Artur C., Glauche, Ingmar

    مصطلحات موضوعية: CML, immunological control, tyrosine kinase inhibitor, treatment stop, dose reduction, mathematical modelling, CML, immunologische Kontrolle, Tyrosinkinase-Inhibitor, Behandlungsstopp, Dosisreduktion, mathematische Modellierung, info:eu-repo/classification/ddc/610, ddc:610

    العلاقة: info:eu-repo/grantAgreement/CAPES/Post-doctoral research abroad Grant/88881.119037/2016-01/

    الإتاحة: https://tud.qucosa.de/id/qucosa%3A74320Test
    https://tud.qucosa.de/api/qucosa%3A74320/attachment/ATT-0Test/

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy

    المؤلفون: Soderlund, Stina, Persson, Inger, Ilanderd, Mette, Guilhot, Joelle, Hjorth-Hansen, Henrik, Koskenvesa, Perttu, Richter, Johan, Saussele, Susanne, Mustjoki, Satu, Olsson-Strömberg, Ulla

    المساهمون: Integrins in immunity, HUS Comprehensive Cancer Center, Department of Clinical Chemistry and Hematology, Department of Oncology, Hematologian yksikkö, Medicum, University of Helsinki

    مصطلحات موضوعية: Chronic myeloid leukemia, Tyrosine kinase inhibitor, Treatment free remission, Proteomics, Immunology, TREATMENT-FREE REMISSION, PHILADELPHIA-CHROMOSOME, TRANS-PRESENTATION, CML PATIENTS, CELL FATE, FOLLOW-UP, IMATINIB, METASTASIS, SERUM, NK, 3122 Cancers

    وصف الملف: application/pdf

    العلاقة: Funding for this sub-study was supplied by the Nordic Cancer Union and Lions Uppsala.; Soderlund , S , Persson , I , Ilanderd , M , Guilhot , J , Hjorth-Hansen , H , Koskenvesa , P , Richter , J , Saussele , S , Mustjoki , S & Olsson-Strömberg , U 2020 , ' Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy ' , Leukemia Research , vol. 90 , 106310 . https://doi.org/10.1016/j.leukres.2020.106310Test; ORCID: /0000-0002-0816-8241/work/70951997; 3733da6a-6ec9-4050-b8c8-cbe648da5ae3; http://hdl.handle.net/10138/325108Test; 000516786500006

    الإتاحة: http://hdl.handle.net/10138/325108Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML

    المؤلفون: Hähnel, Tom, Baldow, Christoph, Guilhot, Joelle, Guilhot, Francois, Saussele, Susanne, Mustjoki, Satu, Jilg, Stefanie, Jost, Philipp J., Dulucq, Stephanie, Mahon, Francois-Xavier, Roeder, Ingo, Fassoni, Artur C., Glauche, Ingmar

    المساهمون: HUS Comprehensive Cancer Center, Department of Clinical Chemistry and Hematology, Hematologian yksikkö, TRIMM - Translational Immunology Research Program, Department of Oncology, University of Helsinki

    مصطلحات موضوعية: CHRONIC MYELOID-LEUKEMIA, CHRONIC MYELOGENOUS LEUKEMIA, TYROSINE KINASE INHIBITORS, MAJOR MOLECULAR RESPONSE, IMATINIB DISCONTINUATION, STEM-CELLS, DYNAMICS, THERAPY, TERM, PERSPECTIVE, 3122 Cancers

    وصف الملف: application/pdf

    العلاقة: We thank all patients and hospital staff for providing this valuable data for scientific assessment. This work was supported by the German Federal Ministry of Education and Research (www.bmbf.de/en/), grant number 031A424 "HaematoOpt" (to I. Roeder) and grant number 031A315 "MessAge" to I. Glauche), as well as the ERA-Net ERACoSysMed JTC-2 project "prediCt" (project number 031L0136A to I. Roeder). The research of A. C. Fassoni was supported by the Excellence Initiative of the German Federal and State Governments (Dresden Junior Fellowship) and by CAPES/Pos-Doutorado no Exterior Grant number 88881.119037/2016-01. S. Mustjoki was supported by Finnish Cancer Organizations, Sigrid Juselius Foundation, and Gyllenberg Foundation.; Hähnel , T , Baldow , C , Guilhot , J , Guilhot , F , Saussele , S , Mustjoki , S , Jilg , S , Jost , P J , Dulucq , S , Mahon , F-X , Roeder , I , Fassoni , A C & Glauche , I 2020 , ' Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML ' , Cancer Research , vol. 80 , no. 11 , pp. 2394-2406 . https://doi.org/10.1158/0008-5472.CAN-19-2175Test; ORCID: /0000-0002-0816-8241/work/75946748; 5e6336f2-37fa-43b8-a507-270622b3ee1f; http://hdl.handle.net/10138/331937Test; 000537843200028

    الإتاحة: http://hdl.handle.net/10138/331937Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients

    المؤلفون: ROUSSELOT, Philippe, MOLLICA, Luigina, GUILHOT, Joelle, GUERCI, Agnes, NICOLINI, Franck E., ETIENNE, Gabriel, LEGROS, Laurence, CHARBONNIER, Aude, COITEUX, Valerie, DARTIGEAS, Caroline, ESCOFFRE-BARBE, Martine, ROY, Lydia, CONY-MAKHOUL, Pascale, DUBRUILLE, Viviane, GARDEMBAS, Martine, HUGUET, Francoise, REA, Delphine, CAYSSIALS, Emilie, GUILHOT, Francois, BERGERON, Anne, MOLIMARD, Mathieu, MAHON, Francois-Xavier, CAYUELA, Jean-Michel, BUSQUE, Lambert, BOUCHET, Stephane

    مصطلحات موضوعية: Pharmacology, Chronic leukaemia, Tyrosine kinases, Sciences du Vivant [q-bio]/Santé publique et épidémiologie

    العلاقة: https://oskar-bordeaux.fr/handle/20.500.12278/110197Test

    الإتاحة: https://doi.org/20.500.12278/110197Test
    https://doi.org/10.1111/bjh.17654Test
    https://oskar-bordeaux.fr/handle/20.500.12278/110197Test
    https://hdl.handle.net/20.500.12278/110197Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

    المؤلفون: Pfirrmann, Markus, Clark, Richard E., Prejzner, Witold, Lauseker, Michael, Baccarani, Michele, Saussele, Susanne, Guilhot, François, Heibl, Sonja, Hehlmann, Rüdiger, Faber, Edgar, Turkina, Anna, Ossenkoppele, Gert, Höglund, Martin, Zaritskey, Andrey, Griskevicius, Laimonas, Olsson-Strömberg, Ulla, Everaus, Hele, Koskenvesa, Perttu, Labar, Boris, Sacha, Tomasz, Zackova, Daniela, Cervantes, Francisco, Colita, Adriana, Zupan, Irena, Bogdanovic, Andrija, Castagnetti, Fausto, Guilhot, Joëlle, Hasford, Joerg, Hochhaus, Andreas, Hoffmann, Verena S.

    المصدر: http://lobid.org/resources/99370672770606441Test#!, 34(8):2138-2149.

    مصطلحات موضوعية: Adolescent [MeSH], Female [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Protein Kinase Inhibitors/therapeutic use [MeSH], Risk factors, Epidemiology, Article, Male [MeSH], Leukemia, Myelogenous, Chronic, BCR-ABL Positive/mortality [MeSH], Prognosis [MeSH], Young Adult [MeSH], Probability [MeSH], BCR-ABL Positive/drug therapy [MeSH], Registries [MeSH]

    العلاقة: https://repository.publisso.de/resource/frl:6471062Test; https://doi.org/10.1038/s41375-020-0931-9Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387299Test/

    الإتاحة: https://doi.org/10.1038/s41375-020-0931-9Test
    https://repository.publisso.de/resource/frl:6471062Test
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387299Test/

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study

    المؤلفون: Meyran, Deborah, Petit, Arnaud, Guilhot, Joelle, Suttorp, Meinolf, Sedlacek, Petr, de Bont, Eveline, Li, Chi Kong, Kalwak, Krzysztof, Lausen, Birgitte, Culic, Srdjana, de Moerloose, Barbara, Biondi, Andrea, Millot, Frédéric

    المساهمون: Université Paris Cité (UPCité), AP-HP Hôpital universitaire Robert-Debré Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Trousseau APHP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CIC Poitiers – Centre d'investigation clinique de Poitiers (CIC 1402), Université de Poitiers = University of Poitiers (UP)-Centre hospitalier universitaire de Poitiers = Poitiers University Hospital (CHU de Poitiers La Milétrie )-Direction Générale de l'Organisation des Soins (DGOS)-Institut National de la Santé et de la Recherche Médicale (INSERM)

    المصدر: ISSN: 0959-8049 ; European Journal of Cancer ; https://hal.science/hal-03492159Test ; European Journal of Cancer, 2020, 137, pp.224 - 234. ⟨10.1016/j.ejca.2020.06.024⟩.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: hal-03492159; https://hal.science/hal-03492159Test; https://hal.science/hal-03492159/documentTest; https://hal.science/hal-03492159/file/S0959804920303579.pdfTest; PII: S0959-8049(20)30357-9

    الإتاحة: https://doi.org/10.1016/j.ejca.2020.06.024Test
    https://hal.science/hal-03492159Test
    https://hal.science/hal-03492159/documentTest
    https://hal.science/hal-03492159/file/S0959804920303579.pdfTest

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin /

    المؤلفون: Lauseker, Michael, Bachl, Katharina, Turkina, Anna, Faber, Edgar, Prejzner, Witold, Olsson-Strömberg, Ulla, Baccarani, Michele, Lomaia, Elza, Zackova, Daniela, Ossenkoppele, Gert, Griškevičius, Laimonas, Schubert-Fritschle, Gabriele, Sacha, Tomasz, Heibl, Sonja, Koskenvesa, Perttu, Bogdanovic, Andrija, Clark, Richard E, Guilhot, Joelle, Hoffmann, Verena S, Hasford, Joerg, Hochhaus, Andreas, Pfirrmann, Markus

    المصدر: American journal of hematology., Hoboken : Wiley, 2019, vol. 94, no. 11, p. 1236-1243. ; ISSN 0361-8609 ; eISSN 1096-8652

    مصطلحات موضوعية: chronic myeloid leukemia, advanced phase, registry, prognosis

    وصف الملف: application/pdf

    العلاقة: https://epublications.vu.lt/object/elaba:40777070/40777070.pdfTest; https://repository.vu.lt/VU:ELABAPDB40777070&prefLang=en_USTest

    الإتاحة: https://doi.org/10.1002/ajh.25628Test
    https://repository.vu.lt/VU:ELABAPDB40777070&prefLang=en_USTest

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia

    المؤلفون: Millot, Frédéric, Maledon, Natacha, Guilhot, Joelle, Güneş, Adalet Meral, Kalwak, Krzysztof, Suttorp, Meinolf

    المساهمون: CIC Poitiers – Centre d'investigation clinique de Poitiers (CIC 1402), Université de Poitiers = University of Poitiers (UP)-Centre hospitalier universitaire de Poitiers = Poitiers University Hospital (CHU de Poitiers La Milétrie )-Direction Générale de l'Organisation des Soins (DGOS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Pediatric Hematology and Oncology (MHH), Medizinische Hochschule Hannover = Hannover Medical School (MHH)

    المصدر: ISSN: 0959-8049 ; European Journal of Cancer ; https://hal.science/hal-03486171Test ; European Journal of Cancer, 2019, 115, pp.17 - 23. ⟨10.1016/j.ejca.2019.03.020⟩.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: hal-03486171; https://hal.science/hal-03486171Test; https://hal.science/hal-03486171/documentTest; https://hal.science/hal-03486171/file/S0959804919302229.pdfTest; PII: S0959-8049(19)30222-9

    الإتاحة: https://doi.org/10.1016/j.ejca.2019.03.020Test
    https://hal.science/hal-03486171Test
    https://hal.science/hal-03486171/documentTest
    https://hal.science/hal-03486171/file/S0959804919302229.pdfTest

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Oral CHOP‐like chemotherapy in 60–80 years‐old patients with diffuse large B‐cell lymphoma

    المؤلفون: Guidez, Stephanie, Lacotte‐Thierry, Laurence, Tomowiak, Cecile, Princet, Isabelle, Dreyfus, Brigitte, Olivier, Gaelle, Fleck, Emmanuel, Corby, Anne, Motard, Carine, Barrier, Jocelyn, Machet, Antoine, Le Dû, Katell, Debiais‐Delpech, Celine, Chabin, Michele, Leleu, Xavier, Guilhot, Joëlle, Delwail, Vincent

    المساهمون: Roche, Amgen Foundation

    المصدر: British Journal of Haematology ; volume 186, issue 6 ; ISSN 0007-1048 1365-2141

    الإتاحة: https://doi.org/10.1111/bjh.16056Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial

    المؤلفون: Rinaldetti, Sébastien, Pfirrmann, Markus, Manz, Kirsi, Guilhot, Joelle, Dietz, Christian, Panagiotidis, Panayiotidis, Spiess, Birgit, Seifarth, Wolfgang, Fabarius, Alice, Müller, Martin, Pagoni, Maria, Dimou, Maria, Dengler, Jolanta, Waller, Cornelius F., Brümmendorf, Tim H., Herbst, Regina, Burchert, Andreas, Janßen, Carsten, Goebeler, Maria Elisabeth, Jost, Philipp J., Hanzel, Stefan, Schafhausen, Philippe, Prange-Krex, Gabriele, Illmer, Thomas, Janzen, Viktor, Klausmann, Martine, Eckert, Robert, Büschel, Gerd, Kiani, Alexander, Hofmann, Wolf-Karsten, Mahon, François-Xavier, Saussele, Susanne

    مصطلحات موضوعية: ddc:610

    وصف الملف: application/pdf

    العلاقة: https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/22628Test; urn:nbn:de:bvb:20-opus-226281; https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-226281Test; https://doi.org/10.1016/j.clml.2018.02.004Test; https://opus.bibliothek.uni-wuerzburg.de/files/22628/Effect_of_ABCG2.pdfTest

    الإتاحة: https://doi.org/10.1016/j.clml.2018.02.004Test
    https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/22628Test
    https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-226281Test
    https://opus.bibliothek.uni-wuerzburg.de/files/22628/Effect_of_ABCG2.pdfTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث